Natera
NTRAAustin, United States· Est.
Dedicated to oncology, women’s health, and organ health. Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care.
NTRA · Stock Price
USD 197.37+2.09 (+1.07%)
Market Cap: $27.8B
Historical price data
About
Dedicated to oncology, women’s health, and organ health. Natera’s cell-free DNA tests help protect health and inform more personalized decisions about care.
Diagnostics
Funding History
5Total raised:$436.4M
PIPE$250M
IPO$106.4M
Series C$50M
Series B$20M